Biomatlante - Synthetic bone substitute manufacturer

Since the establishment in 1995, BIOMATLANTE excels in the worldwide market of synthetic bone substitutes.

Positioned among the leaders of this market segment, we develop, manufacture and commercialize our products under our own label, under private labels or OEM. Our product line is used as much in the orthopaedic and trauma surgery as it is used in spine, ENT, stomatology and dental surgery.

Resolute to respond to customer requests and within close collaboration, we offer personalized solutions to fit individual needs.

Our global process integrates a strategy of strong innovation in order to set a bigger reactivity against the evolution and the demands of our market segment.

Agreements concluded with national and international societies and, associated to this a dynamic research and development department allow BIOMATLANTE to have patents and licences rights in biomaterials and new technologies.

Moreover, we maintain partnerships with the CNRS (NATIONAL CENTER FOR SCIENTIFIC RESEARCH), the INSERM (NATIONAL INSTITUTE OF HEALTH AND MEDICAL RESEARCH) and with national and international universities increasing in this way our competency of innovation on technological transfers of new biomaterials in surgery.

New biotechnologies are the holders of the future. Innovating in this field is essential. Today we begin what we shall be tomorrow.

Chantal Gobin

Présidente.